Men with Stage IV breast cancer who are receptive to systemic therapy benefit from su

[News]

Men with Stage IV breast cancer and known estrogen (ER) and progesterone receptor (PR) status benefit from surgical intervention and from trimodal therapy (systemic therapy, surgery, and radiation), according to a study presented at the virtual American College of Surgeons (ACS) Clinical Congress 2021.

More... (https://www.news-medical.net/news/20211025/Men-with-Stage-IV-breast-cancer-who-are-receptive-to-systemic-therapy-benefit-from-surgery.aspx)